Comment on “Clinical effectiveness of polynucleotides TMJ Injections compared to physio- therapy. A 3 months randomized clinical trial” DOI
Waseem Jerjes

British Journal of Oral and Maxillofacial Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

In reply to the Letter to Editor regarding “Clinical effectiveness of polynucleotides TMJ injections 1 compared to physiotherapy. A 3 months randomized clinical trial” DOI
Niccolò Cenzato,

Roberta Crispino,

Margherita Tumedei

et al.

British Journal of Oral and Maxillofacial Surgery, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

0

Comment on “Clinical effectiveness of polynucleotide TMJ injection compared with physiotherapy: a 3-month randomised clinical trial” DOI

Srinivedha Cv,

Rosmy George,

Raghu Kumaravelu

et al.

British Journal of Oral and Maxillofacial Surgery, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

0

Polynucleotides High Purification Technology (PN HPTTM) Injection Improves Pain Status and Functional Impairment in Hip and Shoulder Tendinitis DOI Open Access

Paolo Gervaso,

Massimiliano Minale,

Niccola Funel

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(5), P. 1404 - 1404

Published: Feb. 20, 2025

Background/Objectives: Tendinopathy is the preferred term to describe various tendon pathologies, including paratendinitis, tendinitis, and tendinosis, in absence of histopathological evidence biopsy specimens. The management tendinopathies challenging; rest, physiotherapy (such as eccentric training), injections, shock waves, orthotics, medical therapy, surgery are main therapeutic options offered patient. conservative treatment still difficult, but several have been proposed, use anti-inflammatory molecules. In this retrospective study, we aimed assess efficacy a approach improving pain functional improvement hip bursitis (HB) biceps tendinitis (BT) patients. Methods: A series data concerning application Polynucleotides High Purification Technology (PN HPTTM) 47 patients with BT HB was analyzed. All received three bi-weekly injections PN HPTTM (T0–T2). Follow-up visits were performed at T3 (8 weeks from T2) T4 (24 T2). Both visual analog scale (VAS) for assessment impairment (FI) scores processed form anonymized clinical evaluations. Results: Statistically significant differences (p < 0.001) reduction (−85%) (+86%) found end treatment. levels patient satisfaction (PS) Clinical Global Improvement—Impression (CGI-I) equal 93% 98%, respectively. According analyses, other (e.g., gender, age, BMI) did not appear influence positive outcomes. Conclusions: shown improve both deterioration tendonitis similar manner treatments. These analyses may open up new avenues implementation approaches tendinitis.

Language: Английский

Citations

0

Combined Intra-Articular PN HPT™ and Hyaluronic Acid: Regeneration Medicine in Knee Osteoarthritis DOI Open Access

Francesco Barcaro,

Antonella Cerino,

Armando Francesco Cervini

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(9), P. 3043 - 3043

Published: April 28, 2025

Background/Objectives: Natural-origin PN HPT™ (Polynucleotides High Purification Technology) protect and revitalize chondrocytes, synoviocytes, cartilage with a regenerative medicine perspective following intra-articular injection. This six-month, open-label data collection aimed to validate the benefits documented in previous studies of single injection proprietary HPT™/HA-based medical device improving both subjective objective manifestations knee osteoarthritis real-life ambulatory patients genders unilateral or bilateral osteoarthritis. Methods: Efficacy safety assessments, conducted at baseline before HPT™/HA after three six months follow-up, included Lequesne index patient-assessed Numeric Pain Rating Scale (NPRS), which focuses on pain intensity, as primary endpoints. The Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) was secondary endpoint. Results: After months, mean score improved by 43.8% 51.4%, respectively. Concurrently, NPRS improvements were 42.2% 54.7%. Furthermore, 32% investigators 15.5% treated deemed optimal clinical outcomes no worsening. Conclusions: With some limitations due uncontrolled design relying rating scales only, study confirms all findings about combining HA same for

Language: Английский

Citations

0

Response to “Comments on Clinical effectiveness of polynucleotides TMJ Injections compared to physio- therapy. A 3 months randomized clinical trial” DOI
Niccolò Cenzato,

Roberta Crispino,

Antonio Russillo

et al.

British Journal of Oral and Maxillofacial Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

Citations

0

Comment on “Clinical effectiveness of polynucleotides TMJ Injections compared to physio- therapy. A 3 months randomized clinical trial” DOI
Waseem Jerjes

British Journal of Oral and Maxillofacial Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

Citations

0